Marc Kollowich

Marc Kollowich, as Co-Founder and Retired Executive at CBW Pharma, has played a pivotal role in shaping the company's strategic direction and operational excellence within the highly competitive pharmaceuticals industry. His extensive expertise in pharmaceutics, oncology, validation, and GMP standards has been instrumental in establishing CBW Pharma as a trusted full-service pharmaceutical company dedicated to delivering innovative solutions. Throughout his tenure, Marc has overseen key projects that span drug development, market access, and regulatory affairs, ensuring compliance with stringent industry regulations while optimizing product lifecycle management.

His deep understanding of hospital sales and pharmaceutical marketing has enabled CBW Pharma to forge strong relationships with healthcare providers and stakeholders, enhancing market penetration and sales effectiveness. Marc’s leadership in validation processes and SOP development has been critical in maintaining high-quality standards across manufacturing and quality assurance functions. Moreover, his strategic insights into market access and regulatory pathways have facilitated successful product launches and sustained growth in competitive markets.

With a Master’s degree in Pharmaceutical Marketing and Management from the Graduate School of Business Administration Zurich, Marc combines academic rigor with practical industry experience. His skills in sales effectiveness, life sciences, and drug development have consistently driven business development initiatives, positioning CBW Pharma as a reliable partner for pharmaceutical innovation. Today, even in his retired capacity, Marc’s legacy continues to influence the company’s commitment to excellence, innovation, and patient-centric solutions, making him a respected figure in the pharmaceutical community.